Australia leads in hospital discharges for endocrine, nutritional, and metabolic diseases with 509.1 units per 100,000 persons in 2023, followed closely by the Czech Republic and Slovakia. The data indicates a varied trend among countries. Australia and the Czech Republic exhibited positive year-on-year growth, while Slovakia, Hungary, and other European countries generally showed a decrease. Iceland experienced the most significant decline.
Future trends to watch include the potential impact of healthcare policies, demographic shifts, and advancements in treatment and diagnosis. Additionally, countries with declining discharge rates might optimize outpatient care or preventive measures, influencing future hospital data trends.
Top countries in Hospital Discharges for Endocrine, Nutritional and Metabolic Diseases Cases by Country
| # | 10 Countries | Units (Hospital Discharges) Per Hundred Thousand Persons | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Australia | 509.1 | 2023 | +1.74% | +1.39% | View data |
| 2 | 2 Czech Republic | 501.3 | 2023 | +5.45% | +0.97% | View data |
| 3 | 3 Slovakia | 472.8 | 2023 | +4.46% | -0.83% | View data |
| 4 | 4 Hungary | 440.4 | 2023 | +2.44% | -3.21% | View data |
| 5 | 5 France | 432.9 | 2023 | +3.96% | -0.75% | View data |
| 6 | 6 Finland | 318.3 | 2023 | -0.56% | -1.9% | View data |
| 7 | 7 Norway | 304 | 2023 | -0.56% | -1.91% | View data |
| 8 | 8 Italy | 250.7 | 2023 | +5.12% | -0.82% | View data |
| 9 | 9 Netherlands | 227.4 | 2023 | +4.55% | +0.053% | View data |
| 10 | 10 Portugal | 196 | 2021 | +14.22% | View data |
